Mission Bio Launches Tapestri Triomics for Single-Cell Analysis
SOUTH SAN FRANCISCO, Calif. — September 16, 2026 Mission Bio announced the launch of Tapestri® Triomics, a new expansion...
Cancer Research
Advertisement
Elanco Advances Pet Health Innovation as Tick Season Expands
Indianapolis, Indiana, September 15, 2026 Elanco Animal Health is reporting continued momentum in its pet health innovation portfolio as...
Summit Therapeutics Reports Ivonescimab Survival Data at WCLC
Los Angeles, California, September 15, 2026 Summit Therapeutics has announced positive overall survival results from the Phase 3 HARMONi-2...
Eli Lilly to Present New Cardiometabolic Data at EASD 2026
Indianapolis, Indiana, September 15, 2026 Eli Lilly and Company will present new clinical and scientific data for Foundayo (orforglipron),...
Taiho Oncology’s Zipalertinib Improves PFS in EGFR Lung Cancer
Princeton, New Jersey, September 15, 2026 Taiho Oncology has announced positive results from the REZILIENT3 Phase 3 trial, showing...
Advertisements
Aignostics Launches PathoSearch for AI-Driven Pathology Case
Berlin, Germany and New York, NY, September 12, 2026 Aignostics has launched PathoSearch, a new AI-powered visual search engine...
Telomir Advances Telomir-Zn in Human and Canine Osteosarcoma
MIAMI, Fla. — September 14, 2026 Telomir Pharmaceuticals, Inc. announced new research conducted with The Ohio State University College...
Heartvue.ai and Innolitics Gain FDA Clearance for Cardiac MRI AI
Brentwood, Tennessee & Austin, Texas, USA, September 3, 2026 Heartvue.ai and Innolitics have announced that the U.S. Food and...
Akeso Reports Ivonescimab OS Benefit in HARMONi-2
Hong Kong, September 3, 2026 Akeso, Inc. has announced that a prespecified interim analysis of overall survival (OS) in...
HUTCHMED and GSK Partner on KRAS-EGFR Cancer Therapy
Hong Kong, Shanghai & Florham Park, New Jersey, USA, September 3, 2026 HUTCHMED (China) Limited and GSK have entered...
Advertisement
